← Evidence map

ArticleGut2024

CD39 deletion in TCR-engineered T cells enhances antitumour immunity.

Alexander K Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37898545